{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:28:00Z","timestamp":1790882880211,"version":"4.1.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"unspecified","delay-in-days":178,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,4,3]]},"DOI":"10.1080\/21645515.2020.1809266","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T18:28:56Z","timestamp":1600885736000},"page":"1162-1172","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants"],"prefix":"10.1080","volume":"17","author":[{"given":"Johnna","family":"Perdrizet","sequence":"first","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Felipe S.","family":"Santana","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Senna","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1010-276X","authenticated-orcid":false,"given":"Rodrigo Fernandes","family":"Alexandre","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Sini de Almeida","sequence":"additional","affiliation":[{"name":"Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spinardi","sequence":"additional","affiliation":[{"name":"Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-2742","authenticated-orcid":false,"given":"Matt","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.010"},{"key":"e_1_3_3_3_1","first-page":"279","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. Pneumococcal disease. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington (DC): Public Health Foundation; 2015. p. 279\u201396.","edition":"13"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1334555"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30310-4"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000013"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208211"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30734-5"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144739"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30484-5"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.001"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix685"},{"key":"e_1_3_3_15_1","first-page":"21","article-title":"Behavior of Streptococcus pneumoniae serotypes 3 and 19A in Chile","volume":"6","author":"Ministry of Health Chile, Institute of Public Health Chile","year":"2016","unstructured":"Ministry of Health Chile, Institute of Public Health Chile. Behavior of Streptococcus pneumoniae serotypes 3 and 19A in Chile. Lab Surveillance Bull Inst Public Health Chile. 2016;6:21.","journal-title":"Lab Surveillance Bull Inst Public Health Chile"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211767"},{"key":"e_1_3_3_18_1","first-page":"995","article-title":"Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012","volume":"63","author":"Griffin MR","year":"2014","unstructured":"Griffin MR, Mitchel E, Moore MR, Whitney CG, Grijalva CG. Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012. MMWR Morb Mortal Wkly Rep. 2014;63:995\u201398.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu524"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw020"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.05.047"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.032"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1020-49892009001200007"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2017.12.008"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179222"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002436"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00287-5"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1516491"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1701911"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0206-1"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020076"},{"key":"e_1_3_3_32_1","unstructured":"Pan American Health Organization (PAHO). Surveillance Network System for Agents Responsible for Pneumonia and Bacterial Meningitis [Internet]. 2019. https:\/\/www.paho.org\/bra\/index.php?option=com_content&view=article&id=1720:sistema-de-redes-de-vigilancia-dos-agentes-responsaveis-por-pneumonias-e-bacterial-meningitis&Itemid=463"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184204"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-89102011005000028"},{"key":"e_1_3_3_37_1","unstructured":"Ministry of Health Brazil. Executive Secretariat. Extract of bid number 14\/2019. http:\/\/www.in.gov.br\/web\/dou\/-\/extrato-de-inexigibilidade-de-licitacao-n-14\/2019-uasg-250005-162478890."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199915040-00004"},{"key":"e_1_3_3_39_1","first-page":"43","article-title":"Parents\u2019 utilities for outcomes of occult bacteremia","volume":"154","author":"Bennett JE","year":"2000","unstructured":"Bennett JE, Sumner W 2nd, Downs SM, Jaffe DM. Parents\u2019 utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154:43\u201348.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.05.003"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.11.1214"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/713576"},{"key":"e_1_3_3_43_1","first-page":"132","volume-title":"Methodological guidelines: economic evaluation studies of health technologies","author":"Ministry of Health Brazil. Secretariat of Science, Technology and Strategic Inputs","year":"2014","unstructured":"Ministry of Health Brazil. Secretariat of Science, Technology and Strategic Inputs. Methodological guidelines: economic evaluation studies of health technologies. 2 ed. Department of Science and Technology, Brazil; 2014. p. 132.","edition":"2"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2013.816572"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1409116"},{"key":"e_1_3_3_46_1","unstructured":"Trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-na\u00efve adult. ClinicalTrials.gov; 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03760146."},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1568159"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30297-X"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.07.057"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.09.008"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1809266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:55:09Z","timestamp":1709304909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1809266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,3]]}},"alternative-id":["10.1080\/21645515.2020.1809266"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1809266","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}